SCHEMBL25828870

SCHEMBL25828870

CC(C)c1c(F)cc2c(c1Cl)CC2

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.33
HTR2C P28335 2/20 0.33
HTR2B P41595 2/20 0.33
NOTUM Q6P988 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18310647 0.89 HTR2A (0.31) HTR2AHTR2CHTR2B
SCHEMBL25827151 0.81
SCHEMBL18310674 0.77 PNMT (0.34) HTR2AHTR2CHTR2B
SCHEMBL23481727 0.71
SCHEMBL25196687 0.68 ATM (0.30)
SCHEMBL25828856 0.67 EIF4A3 (0.38)
SCHEMBL22763888 0.66 GABRA1 (0.31)
SCHEMBL13747960 0.66 GABRA1 (0.41)
SCHEMBL12295184 0.65 MET (0.37) HTR2AHTR2CHTR2B
SCHEMBL18882777 0.65 LMNA (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125841-A1 HETEROCYCLIC COMPOUND AS POLθ INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF 武汉人福创新药物研发中心有限公司 2023-07-06 WO disclosed